Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Steroid Withdrawal and Novo Donor-specific Anti-HLA Antibodies in Renal Transplant Patients: a Prospective, Randomized and Controlled Study in Parallel Groups

NCT02284464 is registered in ClinicalTrials.gov with Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud as lead sponsor.

NCT NCT02284464
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02284464 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Steroid Withdrawal and Novo Donor-specific Anti-HLA Antibodies in Renal Transplant Patients: a Prospective, Randomized and Controlled Study in Parallel Groups
Lead sponsor
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud
Phase
Phase 4
Overall status
Completed
Start date
February 28, 2015
Completion date
December 31, 2019
Enrollment
230 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

other complication of kidney transplant, renal transplant rejection